Glucagon-like peptide-1 receptor agonists and gastrointestinal cancer risk in individuals with type 2 diabetes
Kuo CC, Chuang MH, Li CH, et al.
Diabetologia. Pub. online 5 Jun 2025.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Income and severe hypoglycemia in type 2 diabetes
Kim M, Han K, Lee K, et al.
JAMA Netw Open. 2025;8(6):e2513293.
Leggi
Biomarkers in diabetic nephropathy: a comprehensive review of their role in early detection and disease progression monitoring
Wani ZA, Ahmed S, Saleh A, et al.
Diabetes Res Clin Pract. 2025:112292.
Leggi
Kidney disease: the forgotten legacy of type 1 diabetes
Thomas MC, Zoungas S, Hanssen NMJ, et al.
Diabetes Care. 2025:dci250028.
Leggi
Prevention of diabetic ketoacidosis in relatives screened for islet autoantibodies and followed up in the TrialNet Pathway to Prevention study at a single institution in Italy
Martinenghi S, Merolla A, Grogan P, et al.
Diabetologia. Pub. online 29 May 2025.
Leggi
Initiation of continuous glucose monitoring and mortality in type 2 diabetes
Reaven PD, Macwan S, Newell M, et al.
Diabetes Technol Ther. Pub. online 28 May 2025.
Leggi
Once-weekly mazdutide in chinese adults with obesity or overweight
Ji L, Jiang H, Bi Y, et al.
N Engl J Med. Pub. online 25 May 2025.
Leggi
The impact of insulin pump therapy compared to multiple daily injections on complications and mortality in type 1 diabetes: a real-world retrospective cohort study
Haughton S, Riley D, Berry S, et al.
Diabetes Obes Metab. Pub. online 19 May 2025.
Leggi
In utero exposure to maternal hyperglycemia and offspring type 2 diabetes genetic risk score are independently associated with risk of impaired glucose tolerance in youth
Dieguez AC, Kuang A, Josefson JL, et al.
Diabetes Care. 2025:dc242891.
Leggi
Glucose-lowering medications, glycemia, and cognitive outcomes: the GRADE randomized clinical trial
Luchsinger JA, Rosin SP, Kazemi EJ, et al.
JAMA Intern Med. 2025:e251189.
Leggi